A detailed history of Founders Fund V Management, LLC transactions in Cyclo Therapeutics, Inc. stock. As of the latest transaction made, Founders Fund V Management, LLC holds 480,708 shares of CYTH stock, worth $350,916. This represents 7.36% of its overall portfolio holdings.

Number of Shares
480,708
Previous 480,708 -0.0%
Holding current value
$350,916
Previous $610 Million 29.13%
% of portfolio
7.36%
Previous 72.16%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$0.93 - $1.88 $447,058 - $903,731
480,708 New
480,708 $764,000

Others Institutions Holding CYTH

About Cyclo Therapeutics, Inc.


  • Ticker CYTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 8,439,440
  • Market Cap $6.16M
  • Description
  • Cyclo Therapeutics, Inc., a clinical stage biotechnology company, develops cyclodextrin-based products for the treatment of various diseases. Its lead drug candidate is Trappsol Cyclo, an orphan drug, which is Phase III clinical trials for the treatment of Niemann-Pick Type C disease. The company also develops Trappsol Cyclo for the treatment of...
More about CYTH
Track This Portfolio

Track Founders Fund V Management, LLC Portfolio

Follow Founders Fund V Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Founders Fund V Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Founders Fund V Management, LLC with notifications on news.